Conferences

Catalog

Abstracts

Calendar

North Carolina Hematologic Malignancies Symposium 2026: Evidence-Based Updates and Clinical Decision-Making in Lymphoma, CLL, Myeloma, AML, and MPNs

Venue: Washington Duke Inn & Golf Club, 3001 Cameron Blvd, Durham, NC, 27705, United States

Start Date: October 16, 2026

Overview

Trusted by Thousands of Attendees
Across Our Events

14+

Email if you have questions

Our Speakers

Planning Committee

Binay Shah, MD, MHA

Conference Director

Binayatara

Joshua Zeidner

Conference Co-Chair

Debbie Stephens, DO

Conference Co-Chair

University of North Carolina

Lindsay Rein, MD

Planning Committee

Duke University

Nilanjan Ghosh, MD, PhD

Planning Committee

Atrium Health Levine Cancer Institute, Wake Forest University School of Medicine

Sascha Tuchman, MD

Planning Committee

University of North Carolina at Chapel Hill

Faculty

Andrea Sitlinger, MD

Topic Presenter

Duke Cancer Institute

Ryan W Jacobs, MD

Topic Presenter

Levine Cancer Institute

Lacey Williams, MD

Topic Presenter

University of North Carolina

Thomas LeBlanc, MD

Topic Presenter

Duke Cancer Institute

Daniel Peters, MD

Topic Presenter

Madeleine Burkheart

Topic Presenter

Cristiana Costa

Topic Presenter

Franklin Chen, MD

Topic Presenter

Novant Health Cancer Institute

Matthew McKinney, MD

Topic Presenter

Duke University School of Medicine

Eben Lichtman

Topic Presenter

Matthew McKinney, MD

Topic Presenter

Duke University School of Medicine

Rakhee Vaidya, MD

Topic Presenter

Atrium Health Wake Forest

Agenda

Friday, October 16th, 2026

All timings are in Eastern Time (EDT, GMT-04:00) time.

08:30 AM - 08:35 AMWelcome

08:35 AM - 08:50 AMIntroduction by Binaytara

08:50 AM - 09:35 AMSession 1: Lymphoma

Session Chair: Nilanjan Ghosh, MD, PhD

08:50 AM - 09:00 AM

Treatment of Relapsed or Refractory Marginal Zone Lymphoma – Rakhee Vaidya, MD

09:00 AM - 09:10 AM

Second Line Treatment of Diffuse Large B-cell Lymphoma

09:10 AM - 09:20 AM

Treatment of Relapsed or Refractory Follicular Lymphoma – Matthew McKinney, MD

09:25 AM - 09:35 AM

Panel Discussion

Moderators:

Nilanjan Ghosh, MD, PhD

Panelists:

Matthew McKinney, MD

09:35 AM - 09:45 AMBreak & Exhibits

09:45 AM - 10:30 AMSession 2: CLL

Session Chair: Debbie Stephens, DO

09:45 AM - 09:55 AM

Should we use Pirtobrutinib in Frontline Treatment of CLL? – Andrea Sitlinger, MD

09:55 AM - 10:05 AM

When should we use PVR for relapsed/refractory CLL? – Ryan W Jacobs, MD

10:05 AM - 10:15 AM

When should we use MRD to guide therapy for CLL?

10:15 AM - 10:30 AM

Panel Discussion

Moderators:

Debbie Stephens, DO

Panelists:

Andrea Sitlinger, MD; Ryan W Jacobs, MD

10:30 AM - 11:15 AMSession 3: Multiple Myeloma

Session Chair: Sascha Tuchman, MD

10:30 AM - 10:40 AM

What's the real role for plasma exchange in cast nephropathy? – Cristiana Costa

10:40 AM - 10:50 AM

Who with myeloma really needs IVIG? – Eben Lichtman

10:50 AM - 11:00 AM

What's the optimal way to treat bone disease and enhance bone health in myeloma? – Franklin Chen, MD

11:00 AM - 11:15 AM

Panel Discussion

Moderators:

Sascha Tuchman, MD

Panelists:

Cristiana Costa ; Eben Lichtman ; Franklin Chen, MD

11:15 AM - 12:15 PMLunch & Exhibits

12:15 PM - 01:00 PMSession 4:AML

Session Chair: Joshua Zeidner

12:15 PM - 12:23 PM

Debate: HMA/Venetoclax is the new standard of care for newly diagnosed AML patients irrespective of age (Pro) – Lacey Williams, MD

12:23 PM - 12:31 PM

Debate: HMA/Venetoclax is the new standard of care for newly diagnosed AML patients irrespective of age (Con) – Madeleine Burkheart

12:31 PM - 12:39 PM

Debate: HMA/Venetoclax Triplets will be the standard of care for all older AML patients in the future? (Pro) – Daniel Peters, MD

12:39 PM - 12:47 PM

Debate: HMA/Venetoclax Triplets will be the standard of care for all older AML patients in the future? (Con) – Thomas LeBlanc, MD

12:47 PM - 01:00 PM

Panel Discussion

Moderators:

Joshua Zeidner

Panelists:

Lacey Williams, MD; Daniel Peters, MD; Thomas LeBlanc, MD; Madeleine Burkheart

01:00 PM - 01:45 PMSession 5: Myeloproliferative Neoplasms

Session Chair: Lindsay Rein, MD

01:45 PM - 01:45 PMClosing Remarks & Adjourn

About North Carolina Hematologic Malignancies Symposium 2026: Evidence-Based Updates and Clinical Decision-Making in Lymphoma, CLL, Myeloma, AML, and MPNs

Overview

Faculty and committee

Our Speakers

Planning Committee

Faculty

Conference program and agenda

Agenda

Venue and map

Registration and pricing

Exhibitors and sponsorship

Agenda